RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

Clinical trial NCT07100184 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07100184
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-expressing High-risk or Very High-risk NMIBC Without Visible Foci of Disease After TURBT

Start date: 2025-09-01
Primary completion: 2028-05-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.